Pharma

Your Article Summary

See Latest Articles

Zila Merger Agreement with Tolmar Amended to Reflect Higher Stock Price
Zila, 07/30/09

Zila, Inc. announced that its definitive merger agreement with Tolmar Holding, Inc., a privately held, pharmaceutical research, development, manufacturing and commercial operations company, has been amended to reflect a higher price per share. Under the terms of the revised agreement, Tolmar will acquire, for cash, all of Zila's common stock for $0.45 per share and preferred stock for $0.50 per share.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis to acquire Oenobiol, French leader in nutritional beauty supplements
Sanofi-aventis, 11/02/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

See All of M&A/Partnerships